Matches in Nanopublications for { ?s ?p "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP901681.RAALrIhLMj115iayDLZndMsLR_RifJFHBBgBcVBgYln9c130_assertion description "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP901681.RAALrIhLMj115iayDLZndMsLR_RifJFHBBgBcVBgYln9c130_provenance.
- NP883685.RAi4dfWriGm5cJGFE9p8G1L9aCeRxayXJ1McwGO9vnHtA130_assertion description "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883685.RAi4dfWriGm5cJGFE9p8G1L9aCeRxayXJ1McwGO9vnHtA130_provenance.
- NP874301.RAsO2ejB5SlzDmkgNx1aZigyW5xyYTUhWtMWB9HYB3EWA130_assertion description "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874301.RAsO2ejB5SlzDmkgNx1aZigyW5xyYTUhWtMWB9HYB3EWA130_provenance.
- NP826429.RAmvRnF1gRbp8XjxuvajG4JttaT55frKmhS2bq4rb_oCI130_assertion description "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826429.RAmvRnF1gRbp8XjxuvajG4JttaT55frKmhS2bq4rb_oCI130_provenance.
- NP803342.RAYTZjfU3icSUB2zRMsbtTzjCWNYypq0yzXpQa6bUmn0A130_assertion description "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803342.RAYTZjfU3icSUB2zRMsbtTzjCWNYypq0yzXpQa6bUmn0A130_provenance.
- NP978462.RAf1uCj9AOj8IUBoXw4vOnhHbEL4sQz6iuZ3lX6j5PhVw130_assertion description "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978462.RAf1uCj9AOj8IUBoXw4vOnhHbEL4sQz6iuZ3lX6j5PhVw130_provenance.
- assertion description "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP734288.RArYxdxNnZ3IF3UuzFfDxT1AgU4dK4d9eZEZyk0GImIi0130_assertion description "[To extend these results we searched for mutations of ASXL1 in a series of chronic myelomonocytic leukaemias, a disease classified as MDS/Myeloproliferative disorder, and found mutations in 17 out of 39 patients (43%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734288.RArYxdxNnZ3IF3UuzFfDxT1AgU4dK4d9eZEZyk0GImIi0130_provenance.